Invera Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Sell
5,597
-81
-1% -$18.9K 0.88% 37
2025
Q4
$1.18M Sell
5,678
-154
-3% -$30.5K 0.74% 40
2025
Q3
$1.08M Sell
5,832
-7
-0.1% -$1.2K 0.67% 46
2025
Q2
$892K Sell
5,839
-821
-12% -$126K 0.58% 57
2025
Q1
$1.1M Buy
+6,660
New +$1.04M 0.71% 50
2024
Q1
Sell
-6,288
Closed -$986K 83
2023
Q4
$986K Buy
+6,288
New +$964K 0.62% 56

Other funds holding JNJ

Invera Wealth Advisors's JNJ Position: Q1 2026 in Review

Invera Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q1 2026, selling an estimated $18.9K and leaving 5,597 shares worth $1.37M. The position accounts for 0.88% of the portfolio, ranked #37.

Invera Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 6 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Invera Wealth Advisors held 5,597 shares of Johnson & Johnson worth $1.37M as of Q1 2026.
  • Invera Wealth Advisors sold 81 Johnson & Johnson shares in Q1 2026, an estimated $18.9K.
  • Johnson & Johnson made up 0.88% of Invera Wealth Advisors's portfolio in Q1 2026, its #37 holding.
  • Invera Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 6 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Invera Wealth Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.